A Comprehensive Review of Differences between Osteoradionecrosis and Medication-related Osteonecrosis of the Jaw

References (60)

1. 1 Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic [DOI]
2. 2 American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update [DOI]
3. 3 Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus [DOI]
4. 4 Osteoradionecrosis: A new concept of its pathophysiology [DOI]
5. 5 Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer [DOI]
6. 6 The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway [DOI]
7. 7 The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data [DOI]
8. 8 Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected osteoradionecrosis [DOI]
9. 9 Osteoradionecrosis: Clinical experience and a proposal for classification [DOI]
10. 10 Oral complications of radiotherapy [DOI]
11. 11 The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws [DOI]
12. 12 Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment [DOI]
13. 13 Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases [DOI]
14. 14 In vitro effects of therapeutic ultrasound on cell proliferation, protein synthesis, and cytokine production by human fibroblasts, osteoblasts, and monocytes [DOI]
15. 15 Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy [DOI]
16. 16 Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-containing Bisphosphonates [DOI]
17. 17 EFFECT OF ULTRASOUND ON THE PRODUCTION OF IL-8, BASIC FGF AND VEGF [DOI]
18. 18 A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ) [DOI]
19. 19 Intravenous Bisphosphonate-Related Osteonecrosis of the Jaw: Bone Scintigraphy as an Early Indicator [DOI]
20. 20 Medication-related osteonecrosis of the jaw: Clinical and practical guidelines [DOI]
21. 21 The management of osteoradionecrosis of the jaws – A review [DOI]
22. 22 Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease [DOI]
23. 23 Learning from experience. Proposal of a refined definition and staging system for bisphosphonate‐related osteonecrosis of the jaw (BRONJ) [DOI]
24. 24 Medication-related osteonecrosis of the jaw: A literature review [DOI]
25. 25 Osteoradionecrosis of mandible bone in patients with oral cancer—associated factors and treatment outcomes [DOI]
26. 26 Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients [DOI]
27. 27 Bisphosphonate osteonecrosis of the jaw: A historical and contemporary review [DOI]
28. 28 Imaging of Radiation- and Medication-Related Osteonecrosis [DOI]
29. 29 The conservative management of osteoradionecrosis of the mandible with ultrasound therapy [DOI]
30. 30 Apoptosis in the Osteonecrosis of the Femoral Head [DOI]
31. 31 Masticator space abnormalities associated with mandibular osteoradionecrosis: MR and CT findings in five patients.
32. 32 Management of Antiresorptive Osteonecrosis of the Jaws With Primary Surgical Resection [DOI]
33. 33 Comparison of the histopathological characteristics of osteomyelitis, medication-related osteonecrosis of the jaw, and osteoradionecrosis [DOI]
34. 34 Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis [DOI]
35. 35 Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw [DOI]
36. 36 Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: A comparative study [DOI]
37. 37 Comments on “Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus” [DOI]
38. 38 Image findings of bisphosphonate related osteonecrosis of jaws comparing with osteoradionecrosis [DOI]
39. 39 MRONJ risk of adjuvant bisphosphonates in early stage breast cancer [DOI]
40. 40 Imaging of mandibular osteoradionecrosis [DOI]
41. 41 Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography [DOI]
42. 42 Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat [DOI]
43. 43 Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer [DOI]
44. 44 Mandibular changes on panoramic imaging after head and neck radiotherapy [DOI]
45. 45 Low-intensity ultrasound accelerates mandibular implant bone integration in dogs with mandibular osteoradionecrosis [DOI]
46. 46 Experimental Radio-Osteonecrosis of the Jaws [DOI]
47. 47 Hyperbaric oxygen in total rehabilitation of patients with mandibular osteoradionecrosis [DOI]
48. 48 Osteomyelitis and osteoradionecrosis of the jaws.
49. 49 Hyperbaric Oxygen in Total Rehabilitation of Patients with Mandibular Osteoradionecrosis [DOI]
50. 50 Workshop of European task force on medication‐related osteonecrosis of the jaw—Current challenges [DOI]
51. 51 Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis [DOI]
52. 52 Review and update on drugs related to the development of osteonecrosis of the jaw [DOI]
53. 53 Preclinical models of medication-related osteonecrosis of the jaw (MRONJ) [DOI]
54. 54 Reconstruction of segmental mandibular defects: Current procedures and perspectives [DOI]
55. 55 Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review [DOI]
56. 56 Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management [DOI]
57. 57 Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw [DOI]
58. 58 Diagnostic value of platelet‐lymphocyte ratio and hemoglobin‐platelet ratio in patients with rectal cancer [DOI]
59. 59 CBCT imaging and histopathological characteristics of osteoradionecrosis and medication-related osteonecrosis of the jaw [DOI]
60. 60 Medication-related osteonecrosis of the jaw (MRONJ) treated with piezosurgery – case report and review of literature [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Prediction of Radiotherapy Dose Distribution for Glioblastoma Using Convolutional Neural Network Model — shares topic coverage
• Impact of Radiation-induced Trismus on Patients’ Life Quality — shares topic coverage
• Prolactinoma and Pregnancy: A Study Protocol — shares topic coverage
• Material Selection for Constructing an Intraoral Stent Used in Radiotherapy: Analysis of Density and Structure — shares topic coverage
• Palliative Radiotherapy for Spinal Extramedullary Hematopoiesis in Thalassemia Major — shares topic coverage